Three of the major dividend kings recently reported earnings. Coca-Cola (KO) held their 4-5% sales growth guidance for the year. Zero Sugar volume jumped 13%, and water and tea lines also saw growth. They are leaning into single-serve mini-cans to avoid constantly raising prices. Their dividend yield is currently 2.6%. Procter & Gamble (PG) beat Q3 revenue estimates, bringing in $21.2 billion versus the $20.5 billion expected. Net income rose to $3.9 billion from $3.7 billion last year. Their yield sits at 3%. Johnson & Johnson (JNJ) is seeing results from their pivot to pharma and medical devices. Sales for their blood cancer drug Darzalex hit $4 billion, beating the $3.4 billion estimate. Tremfya also beat estimates with $1.6 billion. The main headwind is Stelara, which lost patent protection and saw sales drop 60% down to $656 million. Their yield is 2.3%.